Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, December 11, 2014
Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505(b)(2) approval pathway, joined inPack to present a seminar, “Non-Clinical and Clinical Study Design Factors in a Clinical Trial Protocol,” on Dec. 9 in ...
read more
Monday, September 17, 2018
Isotopen Technologien München (ITM) has signed a Research Evaluation and Option Agreement for a worldwide exclusive license with Merck KGaA, Darmstadt, Germany.
read more
Thursday, December 14, 2017
Izana Bioscience has launched as a new clinical-stage translational medicine company.
read more
Thursday, September 12, 2019
Zhejiang Jiuzhou has entered into a contractual commitment for the purchase of SNPT, an API manufacturing facility in Suzhou, China.
read more
Wednesday, December 03, 2014
Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion of an acquisition of pharmaceutical manufacturing capacity in Scotland, U.K. The ...
read more
Tuesday, January 28, 2014
Johnson Matthey Catalysis and Chiral Technologies (JMCCT), a business unit of Johnson Matthey Fine Chemical Division (LSE: JMAT), has announced an expansion to its proprietary tethered catalyst technology, and is now offering multi-kilogram ...
read more
Jounce Therapeutics has regained the worldwide rights to JTX-8064 from Bristol Myers Squibb.
read more
Jubilant Cadista Pharmaceuticals is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to the consumer level.
read more
Friday, December 07, 2012
Ken Phelps, one of the nation’s leading experts in the 505(b)(2) development pathway, will be a keynote speaker at the EPPIC Annual Conference in San Francisco, January 6.
read more
Monday, December 23, 2019
Lannett has received approvals from the FDA of its ANDAs for Butalbital, Acetaminophen and Caffeine Capsules.
read more
Dr. Parks, currently Senior Vice President of Marketing & Sales for the DSM Pharmaceutical Products business group of Royal DSM N.V. (NYSE, Euronext: DSM KON), has been appointed President and Business Unit Director of DSM Pharmaceuticals, Inc, as of...
read more
Tuesday, February 03, 2015
Dr. Satyanarayana Chava, Founder and CEO of Laurus Labs Private Limited, India, today announced that the company has launched Laurus Synthesis Inc., a new U.S. pharmaceutical and biotech services entity. Laurus Synthesis Inc. will operate under the ...
read more
Tuesday, February 25, 2020
Levadura Biotechnology has received the ISR for Levadura’s first Patent Cooperation Treaty patent application.
read more
LGM Pharma has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma.
read more
Ligand and SQ Innovation announced a long-term, exclusive commercial license and supply agreements for use of Ligand’s Captisol® technology in the formulation of high-concentration furosemide.
read more